Skip to main content
    S

    Solid Biosciences LLC (SLDB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.23
    -0.25 (-3.86%)

    Market Cap: $723.24M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Solid Biosciences LLC (SLDB) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Solid Biosciences LLC (SLDB) has a market cap of $723.24M and an enterprise value of $597.26M. Its share count is up 59.96% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 17.42% below the market cap, as cash exceeds debt.

    Market Cap$723.24M
    Enterprise Value$597.26M
    Latest price (Nov 17, 2026)$6.23

    Key Dates

    The next earnings report is expected on Mar 4, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 4, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 5.11% in the quarter ended Sep 30, 2026 and grew 90.90% a year over 2 years.

    Shares Outstanding151.03M
    Shares Change (YoY)+59.96%
    Shares Change (QoQ)+5.11%
    Share Count Growth (2Y CAGR)+90.90%

    Price Statistics

    The stock is up 46.93% over 52 weeks and trades 11.63% below its 50-day average.

    Beta (1Y)2.10
    52-Week Change+46.93%
    1-Month Change+5.24%
    3-Month Change-36.04%
    6-Month Change+2.47%
    5-Year Change-79.63%
    Total Return (1Y)+46.93%
    Total Return (3Y CAGR)+34.32%
    Total Return (5Y CAGR)-27.14%
    Return vs SPY (1Y)+27.81%
    Max Drawdown (1Y)-50.99%
    Max Drawdown (3Y)-82.92%
    Sharpe Ratio (1Y)0.44
    Correlation with SPY (1Y)0.38
    50-Day Average$7.05
    200-Day Average$7.68
    52-Week Range$4.40 to $11.45
    RSI (14 Days)43.9
    Average Volume (20 Days)1.26M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 11.99x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio11.99x
    Quick Ratio11.99x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -62.92% over the last 12 months, against a 5-year average of -67.78%.

    Return on Equity (ROE)-62.92%
    Return on Assets (ROA)-55.21%
    ROE (5Y Average)-67.78%
    ROA (5Y Average)-52.68%
    ROIC (5Y Average)-80.94%

    Scores

    SLDB has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$467.00K
    Operating Income-$221.75M
    Pretax Income-$215.27M
    Net Income-$215.27M
    Reported EPS (TTM)-$1.79

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 87.74% of the $389.90M in total assets.

    Cash and Equivalents$125.97M
    Total Debt$0
    Net Cash$125.97M
    Net Cash Per Share$0.83
    Working Capital$334.74M
    Shareholder Equity$342.11M
    Book Value Per Share$2.27
    Total Assets$389.90M
    Total Liabilities$47.79M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.38M of capital spending, operating cash flow left -$200.30M of free cash flow.

    Operating Cash Flow-$198.92M
    Capital Expenditures$1.38M
    Free Cash Flow-$200.30M
    FCF Per Share-$1.87
    Depreciation and Amortization$5.86M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-33.97%
    Tangible Book Per Share Growth (2Y CAGR)-33.97%

    Revenue and profit by year

    Dividends and Yields

    SLDB does not pay a dividend. Its free cash flow yield is -21.29%.

    FCF Yield-21.29%
    Buyback Yield-32.73%
    Shareholder Yield-32.73%

    Stock Splits

    The last split was a 1-for-15 reverse split on Oct 28, 2022.

    Last Split DateOct 28, 2022
    Split TypeReverse split
    Split Ratio1:15

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About SLDB

    What is SLDB's market cap?

    Solid Biosciences LLC has a market cap of $723.24M. Its enterprise value, which adds debt and subtracts cash, is $597.26M.

    How many shares of SLDB are outstanding?

    Solid Biosciences LLC has 151.03M shares outstanding. The count is up 59.96% from a year earlier.

    Does SLDB pay a dividend?

    No. Solid Biosciences LLC does not pay a dividend.

    How much debt does SLDB have?

    Solid Biosciences LLC has $0 of total debt and $125.97M of cash and equivalents, a net cash position of $125.97M.